ArticleJournal of translational medicine2025
Bind: large-scale biological interaction network discovery through knowledge graph-driven machine learning.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- DataXflowGen for GenAI-driven model generation.Scientific reports · 2026Article
- Artificial Intelligence Virtual Organoids (AIVOs).Bioactive materials · 2026Review
- Comic: explainable drug repurposing via contrastive masking for interpretable connections.BMC bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiological systems derive from complex interactions between entities ranging from biomolecules to macroscopic structures, forming intricate networks essential for understanding disease mechanisms and developing therapeutic interventions. Current AI-driven interaction predictors typically operate in isolation, focusing on single tasks and missing the broader picture of how different biological interactions influence each other. Traditional wet-lab approaches for identifying these interactions are expensive, time-consuming, and error-prone. No unified platform currently exists where biologists can predict and analyze multiple types of biological relationships comprehensively, limiting our ability to discover new therapeutic applications and fully understand interconnected biological mechanisms.
methodsWe developed BIND (Biological Interaction Network Discovery), a comprehensive framework utilizing 11 Knowledge Graph Embedding Methods evaluated on 8 million interactions across 30 biological relationships and 129,000 nodes. We implemented a two-stage training strategy to mitigate class imbalance and heterogeneity: initial training on all 30 interaction types to capture inter-relationships, followed by relation-specific fine-tuning. Entity embeddings for each relation from top-performing models (based on MRR) were input into 7 machine learning classifiers separately, creating 1,050 predictive pipelines evaluated through extensive experimentation and hyperparameter optimization. Performance was assessed using F1-scores across all interaction types.
resultsArchitecturally simpler embedding models captured biological interaction patterns, often outperforming complex approaches. The two-stage training strategy achieved improvements up to 26.9% for protein-protein interactions. Optimal embedding-classifier combinations achieved F1-scores ranging from 0.85 to 0.99 across different biological domains. In a drug-phenotype interaction case study, BIND generated 1355 high confidence predictions, with novel interactions successfully validated through existing literature evidence.
conclusionBIND provides a unified web application enabling prediction and analysis of multiple biological interaction types simultaneously, offering superior performance compared to isolated approaches. The platform serves as a valuable tool for biologists to identify unknown interactions for experimental validation, potentially accelerating biomarker discovery and therapeutic development through comprehensive biological interaction network analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.